Tennr vs Tempus AI
A detailed comparison to help you choose between Tennr and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Tennr at 3.9/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Tennr AI-powered healthcare document automation platform | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 3.9 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $99/mo | From $1000/mo |
| Best For | Specialty practices and multi-site provider groups drowning in referral paperwork and denials who can fund a vendor evaluation and implementation project to automate patient intake end to end. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | api accessgdpr compliantteam features | ssoteam features |
| Visit Tennr → | Visit Tempus AI → |
Tennr
Pros
- + Purpose-built RaeLM models evaluated against payer criteria rather than a generic LLM wrapper — the right architecture for medical documentation
- + Covers the full referral chain: intake from fax/portal/email, missing-document chasing, eligibility, prior auth, routing and outbound calls
- + Tennr Network gives referring providers, receiving providers and patients shared real-time referral status, removing phone tag
- + Financially credible: $101M Series C at $605M valuation (June 2025) with reported eight-figure revenue and hundreds of provider organizations
- + Targets first-pass denials and patient conversion — measurable ROI categories for specialty practices
Cons
- - No public pricing at all — ROI comparison against staffing or competitors requires a sales process
- - Demo-only evaluation: no self-serve trial, no developer docs, no public API reference
- - No published accuracy benchmarks for RaeLM despite error-rate claims anchoring the pitch
- - EHR integration list is not public, so compatibility is unverifiable before engaging sales
- - Implementation touches fax lines, portal inboxes and phone scripts — a real change-management load for staff
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Tennr or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 3.9/5 for Tennr, making it the better-rated option in our comparison.
What is the difference between Tennr and Tempus AI?▼
Tennr: Tennr reads inbound healthcare documents such as referrals and faxes, extracts what matters and routes patients to the right care setting. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Tennr or Tempus AI more affordable?▼
Tennr starts at €99/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.